Instrument Inactif

Autres langues F-star Therapeutics, Inc.

Actions

FSTX

US30315R1077

Recherche biotechnologique et médicale

Autres langues

19/04	F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
01/12	F-Star Therapeutics, Inc. Announces Termination of Ryan William Fiehler as Director, Effective December 1, 2025
20/10/25	F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
04/04/25	John Edward Lash of United States of America and The management of F-star Therapeutics, Inc. acquired F-star Therapeutics, Inc. from invoX Pharma Limited in a management buyout transaction.
28/12/24	F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
28/12/24	F-star Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
29/09/23	F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
05/07/23	F-Star Entered into Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generationmulti-Specific Antibodies
22/03/23	F-Star Announces Licence Agreement with Takeda for Second Novel Next-Generation Immuno-Oncology Bispecific Antibody
10/03/23	F-star Therapeutics, Inc.(NasdaqCM:FSTX) dropped from S&P TMI Index
10/03/23	F-star Therapeutics, Inc.(NasdaqCM:FSTX) dropped from S&P Global BMI Index
09/03/23	F star Therapeutics : Acquisition/Asset Disposal - Form 8-K
09/03/23	F-STAR THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
09/03/23	F-star Therapeutics Gets Acquired by invoX Pharma for $161 Million
09/03/23	F-star Therapeutics, Inc.(NasdaqCM:FSTX) dropped from NASDAQ Composite Index
09/03/23	InvoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
09/03/23	Sino Biopharmaceutical Completes $161 Million Acquisition of F-star Therapeutics
08/03/23	InvoX Pharma Limited completed the acquisition of F-star Therapeutics, Inc.
07/03/23	F-star Therapeutics Gets Final Regulatory Nod For Acquisition by Invox Pharma
07/03/23	F-star Therapeutics Shares Rally After Cfius Clears Takeover
07/03/23	F-STAR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
07/03/23	F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
07/03/23	F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
06/03/23	F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
23/02/23	F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)